{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:22:16Z","timestamp":1788092536971,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872494"],"award-info":[{"award-number":["81872494"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272925"],"award-info":[{"award-number":["82272925"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274151"],"award-info":[{"award-number":["82274151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008233","name":"Shanghai Jiao Tong University School of Medicine","doi-asserted-by":"publisher","award":["20240815"],"award-info":[{"award-number":["20240815"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ymthe.2025.08.019","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:18:13Z","timestamp":1755011893000},"page":"5572-5590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Asparaginase enhances CAR-T cell antitumor immunity by asparagine metabolic reprogramming and central memory induction in ALL"],"prefix":"10.1016","volume":"33","author":[{"given":"Xinting","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaibing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixing","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixue","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-8784","authenticated-orcid":false,"given":"Quanjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.08.019_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41591-022-02112-7","article-title":"Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response","volume":"29","author":"Lee","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.08.019_bib2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0140-6736(21)01289-7","article-title":"CD19 CAR T cells for adults with relapsed or refractory acute lymphoblastic leukaemia","volume":"398","author":"Maus","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.08.019_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ccell.2025.02.004","article-title":"Metabolic engineering to facilitate anti-tumor immunity","volume":"43","author":"Schild","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ymthe.2025.08.019_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100908","article-title":"Optimizing use of L-asparaginase\u2013based treatment of adults with acute lymphoblastic leukemia","volume":"53","author":"Douer","year":"2022","journal-title":"Blood Rev."},{"key":"10.1016\/j.ymthe.2025.08.019_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1200\/JCO.19.02292","article-title":"Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia","volume":"38","author":"Kloos","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.08.019_bib6","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1182\/blood.2020006583","article-title":"Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia","volume":"137","author":"Gottschalk Hojfeldt","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.08.019_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41408-022-00688-4","article-title":"Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia","volume":"12","author":"Zhang","year":"2022","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ymthe.2025.08.019_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186648","article-title":"Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signaling","volume":"135","author":"Wei","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.08.019_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s42255-025-01245-6","article-title":"Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations","volume":"7","author":"Chang","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ymthe.2025.08.019_bib10","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cac2.12452","article-title":"Enhancement of CAR-T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins","volume":"43","author":"Qiao","year":"2023","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ymthe.2025.08.019_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/1535-7163.MCT-23-0043","article-title":"Chimeric Antigen Receptor T Cells: Immunotherapy for the Treatment of Leukemia, Lymphoma, and Myeloma","volume":"22","author":"Rodriguez Gil de Montes","year":"2023","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2025.08.019_bib12","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4103\/jcrt.JCRT_1241_20","article-title":"Cancer immunotherapy: Recent advances and challenges","volume":"17","author":"Dhar","year":"2021","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.ymthe.2025.08.019_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","article-title":"Recent advances and discoveries in the mechanisms and functions of CAR T cells","volume":"21","author":"Larson","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2025.08.019_bib14","first-page":"3153","article-title":"Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction","volume":"141","author":"Selli","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.08.019_bib15","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ymthe.2022.01.007","article-title":"D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.08.019_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006239","article-title":"IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM","volume":"11","author":"Zannikou","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.08.019_bib17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cmet.2022.02.009","article-title":"A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy","volume":"34","author":"Ye","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2025.08.019_bib18","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/2326-6066.CIR-22-0565","article-title":"Immunogenetic metabolomics reveals key enzymes that modulate CAR T-cell metabolism and function","volume":"11","author":"Renauer","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.08.019_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2023.2171723","article-title":"Clinical summary of pediatric acute lymphoblastic leukemia patients complicated with asparaginase-associated pancreatitis in SCCLG-ALL-2016 protocol","volume":"28","author":"Wang","year":"2023","journal-title":"Hematology"},{"key":"10.1016\/j.ymthe.2025.08.019_bib20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2017.12.006","article-title":"As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid","volume":"27","author":"Pavlova","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2025.08.019_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s42255-023-00856-1","article-title":"Asparagine restriction enhances CD8(+) T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response","volume":"5","author":"Gnanaprakasam","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ymthe.2025.08.019_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111639","article-title":"CD8(+) T cell metabolic rewiring defined by scRNA-seq identifies a critical role of ASNS expression dynamics in T cell differentiation","volume":"41","author":"Fernandez-Garcia","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.08.019_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41556-020-00615-4","article-title":"Asparagine enhances LCK signalling to potentiate CD8(+) T-cell activation and anti-tumour responses","volume":"23","author":"Wu","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.08.019_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137761","article-title":"Coordination of asparagine uptake and asparagine synthetase expression modulates CD8+ T cell activation","volume":"6","author":"Hope","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.08.019_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.apsb.2012.06.009","article-title":"The application of 2-NBDG as a fluorescent tracer for assessing hepatic glucose production in mice during hyperinsulinemic euglycemic clamp","volume":"2","author":"Liu","year":"2012","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.ymthe.2025.08.019_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2023.12.010","article-title":"Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation","volume":"36","author":"Si","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2025.08.019_bib27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00262-018-2155-7","article-title":"Induction of a central memory and stem cell memory phenotype in functionally active CD4(+) and CD8(+) CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19(+) acute lymphoblastic leukemia","volume":"67","author":"Blaeschke","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2025.08.019_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002555","article-title":"Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies","volume":"9","author":"Tantalo","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.08.019_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2055703","article-title":"Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism","volume":"11","author":"Yang","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ymthe.2025.08.019_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.exphem.2012.04.005","article-title":"Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase","volume":"40","author":"Hermanova","year":"2012","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2025.08.019_bib31","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1182\/bloodadvances.2022006965","article-title":"Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia","volume":"6","author":"Ferguson","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.08.019_bib32","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1038\/sj.leu.2404423","article-title":"The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase","volume":"20","author":"Li","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2025.08.019_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abk1900","article-title":"TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models","volume":"15","author":"Meyran","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.08.019_bib34","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216554","article-title":"\u03b2-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia","volume":"15","author":"Garc\u00eda-Hern\u00e1ndez","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.08.019_bib35","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108069","article-title":"Asparagine reinforces mTORC1 signaling to boost thermogenesis and glycolysis in adipose tissues","volume":"40","author":"Xu","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.ymthe.2025.08.019_bib36","doi-asserted-by":"crossref","first-page":"E789","DOI":"10.1152\/ajpendo.00015.2013","article-title":"Asparagine synthetase: regulation by cell stress and involvement in tumor biology","volume":"304","author":"Balasubramanian","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.08.019_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1182\/bloodadvances.2021005631","article-title":"Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study","volume":"6","author":"Lynggaard","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.08.019_bib38","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1182\/blood-2018-99-118439","article-title":"Monitoring Asparaginase activity in 21 patients with Extranodal NK\/T-cell lymphoma shows a very high proportion of Asparaginase inactivation","volume":"132","author":"Jaccard","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.08.019_bib39","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3324\/haematol.2022.282316","article-title":"Strategies to optimize chimeric antigen receptor T-cell therapy in hematologic malignancies: Chinese experience","volume":"108","author":"Sun","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2025.08.019_bib40","article-title":"CAR-T cell therapy for hematological malignancies: History, status and promise","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ymthe.2025.08.019_bib41","article-title":"Extracellular Domains of CAR Reprogram T-Cell Metabolism Without Antigen Stimulation","author":"Lakhani","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2025.08.019_bib42","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1182\/bloodadvances.2022008272","article-title":"Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment","volume":"7","author":"Panetti","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.08.019_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2015.12.023","article-title":"L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): A novel approach to target ALL","volume":"771","author":"Ali","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2025.08.019_bib44","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1182\/blood-2023-172591","article-title":"Real-World Treatment Patterns Among Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Who Initiated an Asparaginase Treatment after the Approval of Recombinant Erwinia (Rylaze)","volume":"142","author":"Maese","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.08.019_bib45","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1007\/s00277-023-05373-5","article-title":"Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring","volume":"102","author":"Coe-Eisenberg","year":"2023","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ymthe.2025.08.019_bib46","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.clml.2021.07.009","article-title":"SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia","volume":"21","author":"Schmiegelow","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.ymthe.2025.08.019_bib47","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3109\/10428194.2011.596963","article-title":"Prevention and management of asparaginase\/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel","volume":"52","author":"Stock","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ymthe.2025.08.019_bib48","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/leu.2012.102","article-title":"Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia","volume":"26","author":"Liu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.ymthe.2025.08.019_bib49","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41587-019-0246-4","article-title":"In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma","volume":"37","author":"Ye","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.08.019_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121796","article-title":"Co-encapsulation of l-asparaginase and etoposide in dextran nanoparticles for synergistic effect in chronic myeloid leukemia cells","volume":"622","author":"Konhauser","year":"2022","journal-title":"Int. J. Pharm."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625006501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625006501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:24:27Z","timestamp":1779524667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625006501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1525001625006501"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.08.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asparaginase enhances CAR-T cell antitumor immunity by asparagine metabolic reprogramming and central memory induction in ALL","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}